Cargando…

SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells

BACKGROUND: We have developed multiple stable cell lines containing subgenomic HCV RNA that are resistant to treatment with interferon alpha (IFN-α. Characterization of these IFN-α resistant replicon cells showed defects in the phosphorylation and nuclear translocation of STAT1 and STAT2 proteins du...

Descripción completa

Detalles Bibliográficos
Autores principales: Poat, Bret, Hazari, Sidhartha, Chandra, Partha K., Gunduz, Feyza, Balart, Luis A., Alvarez, Xavier, Dash, Srikanta
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948020/
https://www.ncbi.nlm.nih.gov/pubmed/20949125
http://dx.doi.org/10.1371/journal.pone.0013117
_version_ 1782187414529245184
author Poat, Bret
Hazari, Sidhartha
Chandra, Partha K.
Gunduz, Feyza
Balart, Luis A.
Alvarez, Xavier
Dash, Srikanta
author_facet Poat, Bret
Hazari, Sidhartha
Chandra, Partha K.
Gunduz, Feyza
Balart, Luis A.
Alvarez, Xavier
Dash, Srikanta
author_sort Poat, Bret
collection PubMed
description BACKGROUND: We have developed multiple stable cell lines containing subgenomic HCV RNA that are resistant to treatment with interferon alpha (IFN-α. Characterization of these IFN-α resistant replicon cells showed defects in the phosphorylation and nuclear translocation of STAT1 and STAT2 proteins due to a defective Jak-STAT pathway. METHODOLOGY/PRINCIPAL FINDINGS: In this study, we have developed an alternative strategy to overcome interferon resistance in a cell culture model by improving intracellular STAT1 signaling. An engineered STAT1-CC molecule with double cysteine substitutions in the Src-homology 2 (SH2) domains of STAT1 (at Ala-656 and Asn-658) efficiently phosphorylates and translocates to the nucleus of IFN-resistant cells in an IFN-γ dependent manner. Transfection of a plasmid clone containing STAT1-CC significantly activated the GAS promoter compared to wild type STAT1 and STAT3. The activity of the engineered STAT1-CC is dependent upon the phosphorylation of tyrosine residue 701, since the construct with a substituted phenylalanine residue at position 701 (STAT1-CC-Y701F) failed to activate GAS promoter in the replicon cells. Intracellular expression of STAT1-CC protein showed phosphorylation and nuclear translocation in the resistant cell line after IFN-γ treatment. Transient transfection of STAT1-CC plasmid clone into an interferon resistant cell line resulted in inhibition of viral replication and viral clearance in an IFN-γ dependent manner. Furthermore, the resistant replicon cells transfected with STAT1-CC constructs significantly up regulated surface HLA-1 expression when compared to the wild type and Y to F mutant controls. CONCLUSIONS: These results suggest that modification of the SH2 domain of the STAT1 molecule allows for improved IFN-γ signaling through increased STAT1 phosphorylation, nuclear translocation, HLA-1 surface expression, and prolonged interferon antiviral gene activation.
format Text
id pubmed-2948020
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29480202010-10-14 SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells Poat, Bret Hazari, Sidhartha Chandra, Partha K. Gunduz, Feyza Balart, Luis A. Alvarez, Xavier Dash, Srikanta PLoS One Research Article BACKGROUND: We have developed multiple stable cell lines containing subgenomic HCV RNA that are resistant to treatment with interferon alpha (IFN-α. Characterization of these IFN-α resistant replicon cells showed defects in the phosphorylation and nuclear translocation of STAT1 and STAT2 proteins due to a defective Jak-STAT pathway. METHODOLOGY/PRINCIPAL FINDINGS: In this study, we have developed an alternative strategy to overcome interferon resistance in a cell culture model by improving intracellular STAT1 signaling. An engineered STAT1-CC molecule with double cysteine substitutions in the Src-homology 2 (SH2) domains of STAT1 (at Ala-656 and Asn-658) efficiently phosphorylates and translocates to the nucleus of IFN-resistant cells in an IFN-γ dependent manner. Transfection of a plasmid clone containing STAT1-CC significantly activated the GAS promoter compared to wild type STAT1 and STAT3. The activity of the engineered STAT1-CC is dependent upon the phosphorylation of tyrosine residue 701, since the construct with a substituted phenylalanine residue at position 701 (STAT1-CC-Y701F) failed to activate GAS promoter in the replicon cells. Intracellular expression of STAT1-CC protein showed phosphorylation and nuclear translocation in the resistant cell line after IFN-γ treatment. Transient transfection of STAT1-CC plasmid clone into an interferon resistant cell line resulted in inhibition of viral replication and viral clearance in an IFN-γ dependent manner. Furthermore, the resistant replicon cells transfected with STAT1-CC constructs significantly up regulated surface HLA-1 expression when compared to the wild type and Y to F mutant controls. CONCLUSIONS: These results suggest that modification of the SH2 domain of the STAT1 molecule allows for improved IFN-γ signaling through increased STAT1 phosphorylation, nuclear translocation, HLA-1 surface expression, and prolonged interferon antiviral gene activation. Public Library of Science 2010-09-30 /pmc/articles/PMC2948020/ /pubmed/20949125 http://dx.doi.org/10.1371/journal.pone.0013117 Text en Poat et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Poat, Bret
Hazari, Sidhartha
Chandra, Partha K.
Gunduz, Feyza
Balart, Luis A.
Alvarez, Xavier
Dash, Srikanta
SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells
title SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells
title_full SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells
title_fullStr SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells
title_full_unstemmed SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells
title_short SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells
title_sort sh2 modified stat1 induces hla-i expression and improves ifn-γ signaling in ifn-α resistant hcv replicon cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948020/
https://www.ncbi.nlm.nih.gov/pubmed/20949125
http://dx.doi.org/10.1371/journal.pone.0013117
work_keys_str_mv AT poatbret sh2modifiedstat1induceshlaiexpressionandimprovesifngsignalinginifnaresistanthcvrepliconcells
AT hazarisidhartha sh2modifiedstat1induceshlaiexpressionandimprovesifngsignalinginifnaresistanthcvrepliconcells
AT chandraparthak sh2modifiedstat1induceshlaiexpressionandimprovesifngsignalinginifnaresistanthcvrepliconcells
AT gunduzfeyza sh2modifiedstat1induceshlaiexpressionandimprovesifngsignalinginifnaresistanthcvrepliconcells
AT balartluisa sh2modifiedstat1induceshlaiexpressionandimprovesifngsignalinginifnaresistanthcvrepliconcells
AT alvarezxavier sh2modifiedstat1induceshlaiexpressionandimprovesifngsignalinginifnaresistanthcvrepliconcells
AT dashsrikanta sh2modifiedstat1induceshlaiexpressionandimprovesifngsignalinginifnaresistanthcvrepliconcells